Please provide your email address to receive an email when new articles are posted on . Repigmentation of at least 80% was achieved in 36% of areas treated with ASCS compared with 0% of control areas ...
TOKYO--(BUSINESS WIRE)--SanBio Co., Ltd. (TOKYO:4592) (head office: Tokyo, representative director & CEO: Keita Mori) hereby announces that today on July 31 2024, it obtained conditional and ...
3D suspension culture is a promising solution for large-scale, high-quality pluripotent stem cell (PSC) production for cell therapy manufacturing. Gibco™ CTS™ StemScale™ PSC Suspension Medium ...
The European Medicines Agency (EMA) has confirmed a suspension notice for Oxbryta (voxelotor, Pfizer), which is used to treat sickle cell disease (SCD). The medicines regulator said that a higher rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results